Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil

Medical Mycology

Volumn 51, Issue 3, 2013, Pages 225-230

  Moretti, Maria Luiza ^a   Trabasso, Plinio ^a   Lyra, Luzia ^a   Fagnani, Renata ^a   Resende, Mariangela Ribeiro ^a   De Oliveira Cardoso, Luis Gustavo ^a   Schreiber, Angélica Zaninelli ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antifungal use; Brazil; Candida species; Candidemia; Invasive devices

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ARTIFICIAL VENTILATION; BLOODSTREAM INFECTION; BONE MARROW TRANSPLANTATION; BRAZIL; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; HEMATOLOGIC MALIGNANCY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; NONHUMAN; REVIEW; URINARY CATHETER;

EID: 84875195253     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.708107     Document Type: Review

References (40)

1. Pfaller MA, Dikema DJ. Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev 2007; 20: 133- 163 .
2. Pfaller MA, Dikema DJ. Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002 ; 40: 3551-3557 .
3. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of a lbicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: A systematic review. Int J Infect Dis 2010 ; 14: E954-966. Epub 2010 .
4. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia revisited. Clin Infect Dis 2003; 37: 1172- 1177 .
5. Morgan J, Meltzer MI, Plikaytis BD, e t al. Excess mortality, hospital stay, and cost due to candidemia: A case-control using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005 ; 26: 540-547 .
6. Bassetti M, Taramasso L, Nicco E, e t al. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6: E24198. Epub 2011.
7. Das I, Nightngale P, Patel M, Jumaa P. Epidemiology, clinical characteristics, and outcome of candidemia: Experience in a tertiary referral center in UK. Int J Infect Dis 2011; 15: E759-63 .
8. Spilliopoulou A, Vamvakopoulou S, Bartzavali C, e t al. Elevenyear restrospective survey of candidaemia in a university hospital in southwestern Greece. Clin Microbiol Infect 2010 ; 16: 1378-1381 .
9. Hajjeb RA, Sofair AN, Harrison IH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004 ; 42: 1519-1527 .
10. Pfaller MA, Boyken L, Hollis RJ, e t al. In vitro susceptibilities of Candida spp. to caspofungin: Four years of global surveillance. J Clin Microbiol 2006 ; 44: 760-763 .
11. Tortorano AM, Peman J, Bernhardt H, et al. and the ECMM working group on candidaemia. Epidemiology of candidemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004 ; 23: 317-322 .
12. Colombo AL, Nucci M, Salom a o R, e t al. H igh rates of non-a lbicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 1999 ; 34: 281-286 .
13. Colombo AL, Nucci M, Park BJ, e t al. f or the Brazilian Network Candidemia Study. Epidemiology of Candidemia in Brazil: A national sentinel surveillance of Candidemia in eleven medical centers. J Clin Microbiol 2006, 44: 2816-2823 .
14. Motta AL, Almeida GMD, Almeida JN Jr, Burattini MN, Rossi F. Candidemia epidemiology and susceptibility profi le in the largest Brazilian teaching hospital complex. Braz J Infect Dis 2010 ; 15: 441-448 .
15. Levin AS, Costa SF, Mussi NS, et al. C andida parapsilosis fungemia associated with implantable and semi-implantable central venous catheter and the hands of healthcare workers. Diagn Microbiol Infect Dis 1998 ; 30: 243-249 .
16. Kuhn DM, Mukherjee PK, Clark TA, e t al. Candida parapsilosis characterization in an outbreak setting. Emerg Infect Dis 2004 ; 10: 1074-1081 .
17. Bassetti M, Ansaldi F, Nicolini L, e t al. Incidence of candidaemia and relationship with fl uconazole use in an intensive care unit. J Antimicrob Chemother 2009 ; 64: 625-629 .
18. Lass-Fl o rl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009 ; 52: 197-205 .
19. Gir a o E, Levin AS, Basso M, e t al. S even-year trend analysis of nosocomial candidemia and antifungal (fl uconazole and caspofungin) use in intensive care units at a Brazilian University hospital. Med Mycol 2008 ; 46: 581-588 .
20. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009 ; 49: 1-45 .
21. WHO Collaborating Centre for Drug Statistics Methodology [database on the internet]. Oslo (Norway): Norwegian Institute of Public Health. c2004-[cited 2011 Apr 8]. Available from: Http://www.whocc.no/ddd.
22. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1. www.OpenEpi.com, updated 2011/23/06.
23. REDE Interagencial de Informa c a o para a Saude (eds) [Interagency Network for Health Information (eds)]. Indicadores B a sicos Para A Saude No Brasil: Conceitos E Aplica c o es [Basic Indicators For Health In Brazil: Concepts And Applications]. 1st edn. Brasilia: Pan-American Health Organization PAHO/WHO, 2002. [in Portuguese].
24. Hinrichesen SL, Falc a o E, Vilella TAS, et al. Candidemia em hospital terci a rio do nordeste do Brasil. [Candidemia in a tertiary hospital in northeastern Brazil]. Rev Soc Bras Med Trop 2008; 41: 394-398 [in Portuguese] .
25. Colombo AL, Thompson L, Graybill Jr. The north and south candidemia: Issues from Latin America. Drugs Today 2008; 44 (Suppl. A): 1- 34.
26. Nucci M, Queiroz-Telles F, Tob o n AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010; 51: 561-570 .
27. Chen SCA, Marriott D, Playford EG, e t al and the Australian candidaemia study. Candidaemia with uncommon Candida species: Predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 2009 ; 15: 662-669 .
28. Ortega M, Marco F, Soriano A, e t al. C andida species bloodstream infections: Epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect 2011 ; 77: 157-161 .
29. Nucci M, Colombo AL. Candidemia due to Candida tropicalis: Clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 2007 ; 58: 77-82 .
30. White M. The contribution of fl uconazole to the changing epidemiology of invasive Candida infections. Clin Infect Dis 1997; 24: 1129- 1130.
31. Pasqualotto AC, Zimerman RA, Alves SH, e t al. Take control over your fl uconazole prescriptions: The growing importance of Candida glabrata as an agent of candidemia in Brazil. Infect Control Hosp Epidemiol 2008 ; 29: 898-899 .
32. Malani A, Hmoud J, Chiu L, et al. Candida glabrata fungemia: Experience in a tertiary care center. Clin Infect Dis 2005 ; 41: 975-981 .
33. Lin MY, Carmeli Y, Zumsteg J, et al. Prior antimicrobial therapy and risk of hospital-acquired Candida glabrata and Candida krusei fungemia: A case-control study. Antimicrob Agents Chemother 2005 ; 49: 4555-4560 .
34. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: Comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011 ; 38: 65-69. Epub 2011 Apr 22.
35. Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 2011 ; 39: 665-670 .
36. Leenders NH, Oosterheert JJ, Ekkelenkamp MB, et al. Candidemic complications in patients with intravascular catheters colonized with Candida species: An indication for preemptive antifungal therapy? Int J Infect Dis 2011 ; 15: E453-458 .
37. Yapar N, Pullukcu H, Avkan-Oguz V, et al. E valuation of species distribution and risk factors of candidemia: A multicenter case-control study. Med Mycol 2011 ; 49: 26-31 .
38. Abi-Said D, Anaissie E, Uzun O, e t al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997 ; 24: 1122-1128 .
39. Blumberg HM, Jarvis WR, Soucie JM, e t al. Risk factors for C andida bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177- 186.
40. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunossuppressed patients. Lancet 2003 ; 3: 685-702 .